Equities

Detection Technology Oyj

DETEC:HEX

Detection Technology Oyj

Actions
  • Price (EUR)16.65
  • Today's Change-0.10 / -0.60%
  • Shares traded5.95k
  • 1 Year change+16.84%
  • Beta0.8812
Data delayed at least 15 minutes, as of Jul 23 2024 17:00 BST.
More ▼
Improved Notifications for Markets Data Alerts
Improved Notifications for Markets Data Alerts
Want push notifications sent directly to your devices for equity price changes and breaking news stories? Let us know here.
 
Existing alertsView our existing alerts
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Detection Technology Oyj is a Finland-based company providing X-ray imaging products and services for medical, security and industrial applications. It is engaged in design, manufacture and marketing of X-ray imaging components and subsystems, such as detectors, photodiodes, and parts and components. Its security offering includes products for scanning of trains, vehicles and containers, air cargo, baggage and parcels, as well as portable and people scanning. The medical supplies include computer tomography (CT), bone densitometry, mammography, and chest and trauma X-ray. The industrial products comprise detectors for food industry, pharmaceuticals, forestry, automotive, renewable energy, oil and gas, mining, agriculture, recycling and waste sorting, aerospace and defense, and industrial process control.

  • Revenue in EUR (TTM)--
  • Net income in EUR--
  • Incorporated1991
  • Employees478.00
  • Location
    Detection Technology OyjElektroniikkatie 10OULU 90590FinlandFIN
  • Phone+358 207669700
  • Fax+358 207669709
  • Websitehttps://www.deetee.com/
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Nordhealth As36.81m-11.13m125.11m395.00--2.64--3.40-1.68-1.685.5512.470.3561--8.251,110,235.00-10.76---12.25--85.96---30.23------0.00--18.60--21.96------
BioPorto A/S4.34m-7.21m127.26m27.00--20.12--29.33-0.1501-0.15010.09030.10990.41323.667.331,044,452.00-68.68-71.10-100.20-96.5568.0863.38-166.23-239.222.36--0.1354--6.873.5425.81---51.56--
C Rad AB39.25m4.13m128.82m89.0031.995.3026.163.281.431.4313.578.611.204.903.055,266,839.0012.695.0917.967.0245.1443.1210.614.862.43--0.00580.0040.9217.44375.0510.8933.69--
Genovis AB10.88m2.63m159.55m36.0060.719.0844.9414.660.46860.46861.943.130.5084----3,432,784.0012.2818.5613.3721.4566.0965.5124.1523.88----0.27690.0054.5435.56449.56--47.59--
Bactiguard Holding AB18.92m-10.81m186.16m191.00--7.14--9.84-3.60-3.606.309.800.30354.286.001,017,544.00-17.35-7.56-19.82-8.8129.8747.91-57.15-26.281.64-11.900.4129---11.966.46-161.71--8.43--
Stille AB31.02m3.05m188.59m142.0040.823.4141.286.086.006.0060.2071.840.53641.777.183,416,557.005.277.036.358.1946.7643.939.829.850.98797.170.0021.9819.7016.78-2.485.3423.62--
Sedana Medical AB (publ)14.13m-1.96m225.08m83.00--2.6638,639.1615.93-0.2299-0.22991.669.950.15641.248.102,087,443.00-2.17-5.77-2.28-6.0870.5064.06-13.85-36.137.38--0.0043--25.2321.5918.90--42.12--
Detection Technology Oyj-100.00bn-100.00bn245.49m478.00--3.37----------4.97----------9.34--11.96--47.44--8.223.13--0.08153.455.292.027.55-18.03-14.88-9.55
BICO Group AB193.56m-137.69m258.00m837.00--1.01--1.33-22.34-26.3931.7342.970.33982.334.142,555,996.00-24.19---27.59--50.48---71.20--1.95-13.810.3933--6.09---1,889.33------
Medistim ASA44.57m8.61m260.14m152.0030.167.2024.455.845.605.6029.0123.481.030.77656.153,492,704.0019.9522.9324.0728.5279.0278.2519.3120.642.99--0.020675.257.0010.06-8.9112.720.03314.87
RaySearch Laboratories AB (publ)89.88m8.63m319.35m398.0047.646.189.533.552.942.9430.6422.650.53135.652.972,697,136.005.101.297.801.8889.9290.579.602.551.1947.170.403669.0021.1610.26243.060.7648-1.31--
Data as of Jul 23 2024. Currency figures normalised to Detection Technology Oyj's reporting currency: Euro EUR

Institutional shareholders

34.69%Per cent of shares held by top holders
HolderShares% Held
OP Asset Management Ltd.as of 19 Apr 2024984.40k6.72%
SEB Wealth Management Finland Ltd.as of 28 Jun 2024642.00k4.38%
Aktia Bank Plc (Investment Management)as of 27 Jun 2024616.01k4.20%
Keskin�inen Ty�el�kevakuutusyhti� Varmaas of 29 Feb 2024515.00k3.51%
Sp-Fund Management Co. Ltd.as of 29 Feb 2024466.90k3.19%
Keskin�inen El�kevakuutusyhti� Ilmarinenas of 29 Feb 2024435.74k2.97%
Handelsbanken Fonder ABas of 30 Jun 2024431.57k2.95%
Janus Henderson Investors UK Ltd.as of 29 Feb 2024360.84k2.46%
Veritas Pension Insurance Co. Ltd.as of 29 Feb 2024351.77k2.40%
Evli Fund Management Co. Ltd.as of 29 Feb 2024280.00k1.91%
More ▼
Data from 31 Jan 2024 - 30 Jun 2024Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.